Navigation Links
Mettler Toledo Presents In-depth Guidance to Comply with New USP Chapters 41 and 1251 on Balances Used for Quantitative Analysis in the Pharma QC Lab
Date:9/4/2012

LONDON, September 4, 2012 /PRNewswire/ --

USP published their long awaited new drafts to revise the General Chapters 41 "Balances" and 1251 "Weighing on an Analytical Balance" in the Pharmacopeial Forum PF 38(5).

The new drafts are intended to replace the existing chapters and provide a more user-friendly option for the determination of minimum weight. The documents also propose a risk-based approach to determine type and frequency of routine tests, with the omission of daily balance checks from the drafts in accordance with current FDA thinking.

In response to the updated drafts, Dr Klaus Fritsch, Manager Compliance, Global Business Area Laboratory & Weighing Technologies at METTLER TOLEDO presents a contemporary strategy for best-practice compliance with these new guidelines following Good Weighing Practice™; the global Weighing Standard.

In addition to his role at METTLER TOLEDO, Dr Fritsch frequently consults the industry to help achieve compliance with applicable regulations when using weighing systems. He has been actively involved on committees including the USP Expert Panel to revise the General Chapters 41 and 1251.

In his presentation, Dr Fritsch explains how these revised chapters affect balance quality management and applicable SOPs, especially in the framework of determining minimum weight and executing routine testing.

Session highlights:

  • In depth information on the new requirements of the draft to change USP General Chapter 41 "Balances"
  • Which tests have to be periodically performed on balances used for quantitative analysis and which acceptance criteria apply
  • The two alternatives to assess and calculate the minimum weight of your balances
  • Insight into the risk-based approach to performing balance routine testing as recommended by USP General Chapter 1251 "Weighing on an Analytical Balance"
  • The proper weight selection for balance routine testing
  • Why the General Chapters no longer talk about daily balance checks

The full presentation can be viewed exclusively at Pharma IQ now:

http://www.pharma-iq.com/regulatory-legal/webinars/new-drafts-of-usp-chapters-41-and-1251-on-balances

Editors Notes

About GWP

GWP® is the only science-based global standard for efficient lifecycle management of weighing systems, developed from the expertise of METTLER TOLEDO. Lifecycle management according to GWP consists of evaluation, selection, installation, calibration and routine operation. GWP is applicable to all kinds of weighing systems of any manufacturer!

Based on the sound scientific principles of the global weighing standard, METTLER TOLEDO offers two unique commercial services: GWP® Verification & GWP® Recommendation. Service offerings, which guarantee consistent weighing accuracy, audit readiness and feasible cost efficiency, encompassing the entire lifecycle of the weighing equipment http://www.mt.com/gwp

About Mettler Toledo

METTLER TOLEDO is a global manufacturer and marketer of precision instruments for use in laboratory, industrial and food retailing applications. The Company has strong worldwide leadership positions. A significant majority of METTLER TOLEDO instrument sales are in segments in which METTLER TOLEDO is the global leader. In addition to a broad product offering, METTLER TOLEDO has one of the largest global sales and service organizations among precision instrument companies. http://www.mt.com

About Pharma IQ

Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community.

Pharma IQ and IQPC provide useful training courses, conference and expositions for pharmaceutical executives to network and learn the latest pharma business development and trends occurring in organizations today. Pharma IQ focuses on establishing an interactive experience featuring practical, objective and up-to-date insight from pharma industry leaders. http://www.Pharma-IQ.com

About IQPC

IQPC Ltd has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries' trends, technological developments and regulatory landscape.



'/>"/>
SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
3. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
4. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
5. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
8. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
9. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
10. Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510
11. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):